SI',Jere histamine mediated reactions to intrw(}clloltS drltgs ltsed ill anaesthesia may occur as a result of anaphylactic and anaphylactoid reactions. The incidence is rare, but appears to be increasing, The difficulties in diagnosing sltch reactions and in determining the

INTIWDFCTIOX
Severe anaphylactic and anaphylactoid reactions during anaesthesia have been reported sporadically since the 1 H40's, In addition to understanding the nature of such reactions, it is important that anaesthetists know--(a) the propellsit~, of a drug to cause such reactions; (b) the likelihood of the rf'cipient to experience such reactions; (c) the management, both immediate and subsequent, of tllf' patient who ('xpf>riences such reactions.
1. ANAPHYLACTIC ~EACTIONS Anaphylaxis is an increase in susceptibility to a foreign substance induced by repeated exposure,
The term "anaphylaxis" has become synonymous with "hypersensitivity" although it is usually reserved for severe reactions. The basic mechanism involved in anaphylaxi~ is not fully understood.
An allergenic substance will induce in a certain individual, the synthesis of a specific antibody previously called reagin or skin sensitizing antibodv and now known to be IgE illlmunoglobulir{. Prior to this reaction the allergenic substance may combine with a body protein called a hapten. IgE is cytotropic, i.e. it i~ capable of attaching to cell surfaces, The molecule is believed to have two components: the Fc which combines with the target cell, and the Fah component which combines with tIlt' allergen during the s(,nsitizing stage. Combinations of allergen and cell bound IgE results in allostearic transition of JgE exposing a side chain within the Fe region which initiates the ~eries of enzyme reactions involved in the release of histami;;e and other vasoactive amines (Stanworth lH(9) ,
The main cells involved are the tissue mast cells and circulatory basophils and virtually all the intracellular histamine is released (Lichtenstein and Norman IHfl9) . Other factors have been implicated in the response including slow releasing substance of anaphylaxis (SRS-A), kinins and serotonin which although important in animal anaphylaxis have no proven role in human anaphylaxis (Lockey and Bukantz 1 H7 4).
Various classifications of hypersensitivity reactions are described. Loc key and Bukantz (lH74) recognize four types. " (a) (ytotrop£c Antibod.v anaphylaxis, such as that occurring when sensitized guinea pigs are challenged with intraperitoneal antigen, and its features are hypotension, hypothermia and irreversible shock. There is no proven human equivalent. Cytotropic antibody induced anaphylaxis is the type of concern to the anaesthetist.
A hypersensitive state may be produced in a patient by a single challenge or a number of challenges over a period of time.
n. THE ANAPHYLACTOID REACTION
In certain individuals, foreign substances may cause reactions clinically resembling cytotropic antibody induced anaphylaxis. However, no antigen antibody reaction can be detected, and previous exposure has not occurred (Lockey and Burantz 1974) . Such reactions are known as anaphylactoid reactions, and they are due to the release of endogenous histamine from the mast cells, by a direct action. Comroe and Dripps (1946) demonstrated the ability of curare to release histamine in man. Paton (1956) has described the types of agents that can release histamine-1. Sensitizing compounds such as antigens, 2. Compounds damaging tissues such as venoms, 3. Proteolytic enzymes such as trypsin, 4. Surface active agents such as bile salts, 5. Large molecules such as Dextran and egg white, 6. Histamine liberators (dibasic and polybasic compounds), 7. Monobasic compounds such as alkylamines and antihistamines.
III. HISTAMINE RELEASE
Drugs described as histamine releasers have a structure" possessing two or more basic groups carried on, and separated by a sufficient aliphatic or aromatic chain" (Pat on 1956). These drugs included-tubocurarine diallylnortoxiferine gallamine suxamethonium decamethonium laudexium mytolon morphine codeine pethidine (Paton 1956 , Schacter Lund 1970 (Lorenz et al. 1972 , Doenick et al. 1973 . Schacter (1952) believes that drugs that are not primary histamine re leasers can only cause reactions by previous sensitization.
It is equally probable that drugs able to release histamine can cause both anaphylactoid and anaphylactic reactions. The relevance of this in assessing severe reactions to intravenous anaesthetic agents is twofold. In the past, blame has been wrongly ascribed to a particular drug on the basis of previous exposure or tests which merely demonstrate histamine release.
The work of Lorenz et al. (1972) suggests that histamine release occurs in all patients but to an insignificant degree in normals. Westgate, Schultz and van Bergen (1961) and Lorenz et al. (1972) found a higher blood histamine level before anaesthesia in a patient who previously had a severe reaction.
West gate and van Bergen (1962) demonstrated a rise in serum histamine levels in patients who had reactions to tubocurarine and no elevation in normal patients. It is probably reasonable to surmize that the situation is the same for both muscle relaxants and induction agents and that-(a) Previous sensitization is not necessary; (b) There is a group of patients at risk who may manifest a severe histamine mediated reaction to histamine releasing drugs; (c) These patients will respond in different fashion to other histamine releasing drugs, i.e. may not react; (d) Histamine release is of little consequence in normal patients;
(e) Patients who experience severe reactions usually have a history of allergy (Locker and Burantz 1974, Currie 1970) . The elevation in blood histamine has been shown to be at a maximum after five minutes and to persist for at least 30 minutes (Lorenz et al. 1972) . Paton (I mm) has shown the effect to be related to the quantity of the agent injected and the rate of injection.
The clinical effects of anaphylactoid and anaphylactic reactions are identical but the processes involved are not. Morgan and Schild (191) 2) described detailed experiments on guinea pigs which elucidated the differences at a tissue level. They noted release of histamine varied from organ to organ but was similar to chemical releases and antigen, and that chemical release had the same effect on sensitized and nonsensitized tissues. They also found the two processes were able to modify each other, and this varied among tissues. PiJ.ton (1957) . Whether anaesthesia alters the magnitude or incidence of such reactions is unknown. The reactions are more common after induction than during stable anaesthesia (Paton !!I59). Hewer and Lee (1957) note that reactions to dextran are more common in unanaesthetized patients. Bruce and Wingard (197~) state that general anaesthesia offers some protection in some species, modifying the effects of chemica mediator~.
The amount of protection afforded is certainly not of clinical significance.
As the clinical effects of the reactions concern anaesthetists and are identical whatever the cause, they will he called histamine mediated reactions i"n this review.
INclDEXCE OF SEVERE HISTA:\llXE :\IElllATED I{EACTIONS Currie (1970) and Kelly and Bowman (1974) haVE' suggested that the incidence of such reactions is increasing. The number of reported cases certainly is increasing, hut this may well be due to increased numbers of anaesthetics giwn, the greater variety of drugs used, the greater interest of doctors, and the greater utilization of adverse reactions committees and studies.
Smith (l!l74) reviewed tIlt' incidence of atopic disease and found no conclusive evidence that such disease was increasing, and noted a definite variability in incidence among various population:.; and areas. Cluff and Caldwell (1974) gave figures illustrating the epidemic proportions of drug reactions in the V.S.A. Thev showed that the incidence of drug reactions il~ hospital patients varies from;) to 40 per cent and increases with the number of drugs received. Less than If> per cent of such reactions have an allergic basis. H urwitz (HHi9) found that a history of previous drug reactions or allergy predisposed to drug reactions. Of her series, 11 per cent of patients had drug reactions and :.! per cent hypersensitivity reactions.
Of the drug reactions reported to the ~ ew Zealand Adverse Drug Committee in the period 19(;6 to HJ74, :.! per cent were severe histamine mediated reactions and of these 10 per cent were fatal. Antibiotics, vaccines and contrast media caused most of the reactions but 15 per cent were due to drugs used in anaesthesia (Committee on Adverse Drug Reactions 1968-74). Shaw (1974) mentioned two severe histamine mediated reactions in 72,000 anaesthetics over an eight year period.
In the Wellington Hospital group (15,000 anaesthetics per ,,'ear) three severe histamine mediated reactions per year have been recorded over the last three years, and none prior to this. From analysing tIlt' combined experience of \Yellington anaesthetists this is one reaction in ~8 ana.esthetist years. The true incidence is unknown but is rare. 
Bronchospasm
Bronchospasm occurring as a sole symptom during anaesthesia is more likely to be associated with causes other than drugs. Shnider and Papper (1961) reviewed 687 anaesthetics in asthmatics; 6·5 per cent developed asthma during surgery, 2·6 per cent during induction, and 3·9 per cent during maintenance. No increased incidence of asthma was found with thiopentone, curare, or cyclopropane, and no significant difference between regional and general anaesthesia, but an increased incidence was found when patients had an endotracheal tube inserted. The criterion for asthma, however, was clinical wheeze, which in the light of modern thinking and lung function tests, decreases the validity of the study.
The predominant factor causing bronchospasm during anaesthesia is stimulation of the respiratory tract or surgical manipulation where anaesthesia or relaxation is inadequate (Harrison 1966 , Edwards et al. 1956 ). This is especially so in the asthmatic or chronic bronchitic patient. Brandus et al. (1970) described two cases of bronchospasm during anaesthesia as due to tubocurarine and unknown causes respectively. They also noted two previous cases related to passage of a nasogastric tube in a patient unconscious from barbiturate overdose, and cyclopropane for cholecystectomy. Bennett et al. (1970) reported three cases of bronchospasm complicating thoracotomy in which two, they felt, were due to intubation and one to unknown causes. They suggested an association between asthma, mitral stenosis, and the development of bronchospasm. Hamilton (1972 a +b) has severely criticized both cases suggesting light anaesthesia, incorrect position of endotracheal tubes and other mechanical factors were the most likely causes.
Acid aspiration, which may be silent, may also result in bronchospasm although the onset maybe delayed. Currie (1970) notes the difficulty of categorizing bronchospasm and adds the parasympathiomimetic action of thiopentone, and direct irritation of the respiratory tract by halothane as possible causes.
In a number of reported cases of histamine mediated reactions, the first abnormality noted has been difficulty in inflating the lungs. Many other factors may cause this includingincorrect positioning of jaw; light anaesthesia; obstructed endotracheal tube; incorrect ventilator setting; foreign body or secretions in bronchi; lung disease; penumothorax ; spasm of respiratory muscles in response to intubation. Some drugs, particularly the beta blockers may cause bronchospasm as a pharmacological effect. While no one factor can exclude or prove the relationship of bronchospasm and histamine releasing phenomena, the author suggests it is more likely to be related if-(a) the patient is not intubated, (b) the anaesthetic situation is stable and bronchospasm arises shortly after the introduction of a further drug, (c) the bronchospasm occurs in association with other symptoms suggesting histamine mediated reactions, (d) the patient is non-asthmatic or has well controlled asthma.
. Hypotension
The classical features of hypotension related to histamine mediated reactions have been described by Anderton and Hopton (1968) : " Within minutes of the administration of the drug there is a profound circulatory collapse
with hypotension (bloo(l pressure unrecordablp with sphygmomanometer) and marked tach,'-cardia (140-1~O beats/min.). The h\'l)()tension does not rpspond to moderate intra \,(,TlI>lb doses of vasopressor agents and tachycardia ]ll'rsisb after blood pressure has been l'lc\·atpd. Cyanosis usually occurs.
However, hypotension during anaesthesia is more like'" to be due to one or more of man~' possible causes other than histamine reaction.
;{. Gastro-intestinal J)isturbances
Xausea and vomiting are common postoperative disturbances. \\'hen gastro-intestinal disturbances following histamine mediated reactions occur, the\' are likely to be fair'" characteristic \"ith r(~latiwly se'wrp pain of it cramping nature and vomiting with or without diarrhoea, which in our experience (two cases) have persisted about four hours.
Allgiolleurotic Oedema
The occurrence of angioneurotic oedema is highly suggestive of histamine Illediated reactions, especially when restricted t() eve lids and face. However, there are othl'r more frequent causes, e.g. intermittent positive pressure vcntilation and fluid o\·crioad.
:I. Skill Changes
Mild blotching and erythema are not uncommon after intravenous drugs in anaesthesia. The characteristic features of the skin reaction are initial pallor, with erythematous blush; urticaria ma" den'lop (Andert()n ane! Hopton 1 !WH). The crythematous blush in :;evere reactions is most :;triking, and i~ a deep tomato red or purple colour. Both thi" rcaction and urticaria arising during an anacsthetic are virtuall~' diagnostic of a histamine mcdiated reaction.
H. Xasal aJld h,~ve ,\V/1/ptO/JIS
These occur but are not useful diagnostic signs (luring anaesthesia.
J ames and :\usten (I !H:i4) ha \'e described the autops\' findings after fatal anaphdaxi:;. The predominent ahnormality was in the r(':;piratory tract-acute emphysema and oedematous obstruction.
r n the one case without respiratof\' manifestations no causl' of (leath could he found.
B. DETECTI:\G THE })!{1'(; I:\C!{L\II:\.HE])
A large number of factors may confu:;e the issue. A patient may have had six drugs, all potentially capahle of causing such a reaction.
I'rC7'iolls Fxposllrt'
On some ()Cl'<ISlUlb drug:; han: hecn incriminated ()n till' basis ()f pn'\'i()ll:; expo,;ure. As anaphdactic reaction,; and <lnaphdadoid reactions ma\' produce identical clinical features and the drug:; involvcd ma,' producc eitller type of reaction, previoll:; exposure is not necessary f()r a :;cvere reacti()n.
('ross .'icl/siti7,/h·
The pattern of pre\'lOUS eXjlosures and sl'llsitivih' ma\' b(' further confus(,d h\' cross :;cl1siti"it\, or ~ellsitivih' induced h\' mi agent :;haring :;tructural features. Thi:; is ~)articularly i I1lportant with barbiturate:;. Cole (1964) has r(,ported S(,\TIT urticaria dul' t() halothane. Sucll rcacti()ns are rare.
. ...,\·I'illg-c Jlatt'l'ial
It has abo bet'1l suggpsted that the incrcasl' in such reaction:; ma\' be clue t() :;\Tinge material acting a,; a (,()Ilta~ninant. Re'views on the subject of toxicit\· and reacti\·it~· of s~Tillge material suggest such OCCUlTl'IlCl':; are unlikely (:\utian 196:i 1 %1) although SOIllC' brand" mav forl1l water soluble extracts (lll()cllio~a l!Hi;"i). Again, no documented cases exist.
]hllR I'ehicles
I\ccenth' attention has bl'en focu:;sed on the \'chide and preservatives in drug:; which may also ha ye pharmacological effects. The onI\' agent implicated in histamine llIediated reactions is Cremophor EL, tilE' vehicle in althesin and propanidid.
Testing for the Incrilllil1ated f)m{!.
In determining which of t he drugs is responsible, direct challenge ha:; been used (Carrie and Buchanan I!W'j', Kepes and Haimovici 1 !I.',)!J). However, ill view of thc scv(,ritv of the reaction:; such treatment is unjust[ficcl ethical,,·. In addition, false negative ma\' occur, dul' to the latent period of anaphdaxis. Although like"', it i:; abo not proven that after an anapltdadie reactioll, a patient will always rcspond in a similar fashion tn till' same drug, nor is it provell that a dramatic responsc to a Ilistamine releasing drug will occur Oil evef\' occa:;ioll of exposure. Turner d al. (1 !}'j'~) reportcd a case of severe angioneurotic oedema after propanidid, atropint', and suxametholliulll witll a histon' of previous exposure to atropine and suxamethonium.
They were able to demonstrate histamine release from the patient's leucocytes, with all drugs at eight weeks after the incident, with propanidid and atropine only after 17 weeks, and no significant release at 22 weeks. Scratch tests were negative at 30 weeks, as were tests for reaginic antibody. They concluded that the reaction was "anaphylactoid due to an idiosyncratic reaction" which was transient, adding they could only speculate on the possible outcome of further exposure to these drugs.
At present the best that can be said of any test to select one of a group of drugs implicated in a reaction is that the test is of some use if it correlates well with the clinical findings. Tests for anaphylactic reactions and anaphylactoid reactions are rarely interchangeable.
Skin testing is unreliable. Slavin (1974) (Slavin 1974) . Brown (1975) tested 25 consecutive patients with normal response to suxamethonium with intradermal suxamethonium undiluted and obtained a positive weal and flare reaction in all cases.
Other available tests have been discussed by Greaves (1973) , Baer (1974) , Currie (1970) , and Coombes and Gell (1969 Baer (1974) believes the lymphocyte transformation test is highly reliable in distinguishing drugs, but Greaves (1973) criticizes it as insensitive and notes that a high number of hypersensitive patients undergo spontaneous lymphocyte transformation.
Radio immunoassay, while still cumbersome and difficult, is the most exciting and probably of greatest value with drug reactions correlating very well with provocation tests (Greaves 1973) .
At present, however, no one test is sufficiently reliable to exclude a drug which may produce a life threatening reaction, although if a series of tests are done and taken with clinical findings, a fairly reliable degree of evidence may be obtained. THE 
DRUGS
In reviewing the English literature it is apparent that the difficulty in establishing the diagnosis and the drug implicated in severe histamine mediated reactions has lead to a number of misleading reports. Reactions have been attributed to histamine release when an alternative mechanism is equally likely. In addition, individual drugs have been claimed responsible when in fact a number of drugs were used and no adequate testing carried out. In discussing individual drugs the author has excluded those case reports in which the diagnosis may reasonably be considered 111 doubt.
A. INDUCTION AGENTS 1. PROPANIDID Twenty one reactions have been described in detail (Table 1) In the case described by Rozencrantz (1972) , the Jlossibility of th(' reactioIl being due to suxamethonium has not been excluded. From Table 1 it ma\' be seen that both anaph~'lactic and anal;hdactoid reactions occurred. 'I'll(' suggestion made by Ka~' (IHWI) that a patient with a toxic illness ma\' ))(' more likel\' to have such a reaction, does not ~ceI1l to i)e justified. Broncho~pasm was a n'la tin'!\-rare [ca tun' occurring ill only three patients; hypotension, tachycardia, and skin reactions occurred in all but three cases.
(;otla (197:!) described a case where the reaction occurred 90 minutes after the anaesthesia was o"er, and the patient experienced abdominal cramps and profound urticaria commencing Oil the way home. This suhsided ~p()ntaneously and without treatment. The majorit\· of anaph"Jactic reactions occurred within a 1 tol week period of the first ad II1 i Il istra tiOIl.
TABLE
Heports of Severe Histamine Hl"(lcti()/t to Propanidid
Zind]er (lIl1i;"') .. The low incidence of a past history of allergy, stated as present in only two cases, is in contrast to the findings of Currie (1970) with thiopentone anaphylaxis. In the case described by Turner et al. (1972) histamine release could be demonstrated at eight weeks but not at 17 and 22 weeks, suggesting that the susceptibility of the patient was transient in nature. This may also however, be due to the tests used being unsuitable. Only one fatal case is reported (Larard 1970) .
ALTHESIN
Two previously unreported cases have occurred in our hospital.
Case 1
A fit 20 year old male who had no history of asthma or allergies and who had received multiple anaesthetics two years previously, was anaesthetized on 5/2/74 for excision of contractures.
Anaesthesia was with althesin, suxamethonium, nitrous oxide, oxygen and halothane, and was uneventful. Four weeks later he was anaesthetized again and after a premedication of morphine 15 mg and atropine 0·6 mg, he was induced with althesin 0·8 mg/kg. His skin became bright red and his blood pressure became unrecordable. An intravenous infusion of 500 ml dextran 70 was administered and 4 mg dexamethasone and 4 mg chlorpheniramine maleate were given. He awoke after ten minutes and complained of cramping abdominal pain and intense nausea. He vomited four times. A litre of saline was given over two hours at which time his blood pressure was 90/40 mm/Hg and pulse rate 110 beats/min. In six hours his blood pressure was normal and his only complaints were abdominal discomfort and diarrhoea.
Case 2
A fit 23 year old woman with no past history of allergies or asthma was admitted to hospital on 29/8/74. She had a past history of general anaesthesia as a child for squint correction and closure of patent ductus arteriosis. Over the fortnight following admission she had three uneventful anaesthetics with thiopentone, nitrous oxide, oxygen and halothane. On 30/9/74 she had an uneventful anaesthetic with althesin, nitrous oxide, oxygen and halothane. On 21/10/74 she was premedicated with morphine and atropine and induced with 4· 5 ml of althesin. After 2 ml were injected she complained of a racing pulse and dyspnoea and shortly after the althesin injection was completed she became a bright crimson with deeply cyanosed hands and feet. The radial pulse was not palpable. A good spontaneous tidal volume was maintained.
Chlorpheniramine maleate 4 mg was given intravenously and a litre of lactated Ringers solution administered rapidly, after which blood pressure was 60 mm/Hg systolic. Her colour returned to normal after ten minutes. The blood pressure returned to normal six hours postoperatively and the patient complained of abdominal cramps, vomiting and diarrhoea.
Eleven additional cases have been reported (Table 2) . However, in a number of these the diagnosis is equivocal. Avery and Evans (1973) described five cases. In Cases 2 and 3 no attempt is made to exclude either suxamethonium or alcuronium respectively as the causative agent and Case 4 describes a nervous asthmatic in an acute state whose asthma became worse after althesin; no other histamine mediated reaction manifestations occurring.
The case described by Austin et al. (1973) featured bronchospasm as the sole symptom following althesin and pancuronium administration to a patient with a history of mild childhood asthma. Intubation was associated with coughing and considerable bucking which suggests in the absence of subsequent demonstration of sensitivity, intubation was the most likely cause.
As with propanidid, skin changes and hypotension are the most common features and both anaphylactic and anaphylactoid reactions occur. A past history of allergy was only obtained from two patients and again a second exposure between ten days and four weeks was a feature of the anaphylactic reactions. It has been suggested that a cough may herald a reaction to althesin but this occurred only in three cases and is not uncommon after althesin induction.
Propanidid and althesin share both common clinical features and a common vehicle; cremophor EL. It is tempting to ascribe a role in the aetiology of severe histamine mediated reactions to cremophor EL, and the case described by ~otcutt (1973) was a reaction to althesin occurring two weeks after exposure to propanidid. In the case described by Mehta (1973) skin testing to cremophor EL and althesin showed a positive weal and flare reaction but the testing was performed one week after the reaction using concentrated solutions and the results cannot be called conclusive.
Although ..-:
-~did not occur.
)<s ~ not statcd.
(197:!) kl \'l' been unable to demonstrate histamine release in man. This ma\' mean that histaminc release only occurs in sonie people, or that the n1l'thod of measurement is insufficiently sensitive.
A similar situation occurs with pancuronium.
.3. THIOI'Et-;TO:\r:
Allergic reactions to thiopentone were first noted by Hunter (19J:l) .
Sixteen severe histamine mediated reactions definitely due to thiopentone have been described (Table 3) . .\ number of reactions were excluded from consideration. Hoenigsberger (H'43) described a reaction that was probably myocardial depression, and the reaction described by Cole (1968) could equally well haw' hem due to d-tubocurarine. Two reactions described by Fnsworth (197:!) were prohably to thiopentone hut no attcmpt was made to exclude suxamethonium in the first case described, and the reaction described by Kelly and Bowman (1973) while probably thiopentone, could have been due to gallamine. The case described by Dundee et al. (1973) has previously been criticized as not excluding suxamethonium (Gibb 1974) . In this case sensitivity was demonstrated to cremopllor, propanidid, thiopentone and pentobarbitone by leucocyte challenge. but suxamdhoniulll \\'a~ not tested. The most interesting pattern to emerge in the study of thiopentone induced severe histamine mediated reactions is that the majority occur after repeated administrations in contrast to other induction agents. Also a history of exposure to oral barhiturates may be present, and in four cast's a history of allergy to oral barbiturates \vas obtained. However, other patients have shown allergy to some barbiturates and not others. Laryngeal spasm has been described as a feature of some cases. This i~ not a cardinal feature of histamine release but stridor may well be due to laryngeal oedema. Difficulty in ventilation is a common early sign of a reaction, but this is not necessarily associated with bronchospasm or laryngospasm, and seems due to difficulty in maintaining the airway for unknown reasons.
Prolongecl unconsciousness may be a feature. Like propanidid the symptoms and signs may occur late (Fox et al. 1971) . Both anaphylactic and anaphylactoid reactions occur.
OTHER INDCCTIOX AGEl\TS
Thiamylal has caused severe histamine mediated reactions in a patient with an allergic history on first exposure (Thompson et al. 1973) . Methohexitone has been reported to the New 
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· . Unsworth (1972) · . Zealand Adverse Drug Reactions Committee as causing fatal anaphylactic shock but close inspection of the details suggested that a combination of factors occurred and methohexitone was unlikely to be the cause.
MUSCLE RELAXANTS
Anaphylactic reactions to muscle relaxants occur rarely, if at all. The majority of such reactions are anaphylactoid in nature.
The majority of such reactions are in allergic or asthmatic patients with bronchospasm as sole feature. By the very nature of the drugs virtually all patients are intubated. In a number of cases skin sensitivity cannot be demonstrated suggesting five possibilities:
(i) Testing in histamine depleted patient (latent period).
(ii) Another drug. (iii) A different action of the drug. (iv) An alternative cause. (v) In the asthmatic or allergic patient the bronchial musculature is far more susceptible to the effects of histamine than the skin.
d-tubocurarine
Historically d-tubocurarine was the first relaxant shown to produce clinical effects due to histamine release (Comroe and Dripps 1946) . Experimentally it releases histamine to a greater degree than any other relaxant (Sniper 1954) . It has been suggested that because of its histamine releasing effects it should be avoided in asthmatic patients or patients with a history of allergy in spite of the findings of Shnider and Papper (1961) that it causes no increase in bronchospasm in asthmatics. Its bad reputation for causing histamine mediated reactions seems undeserved from the number of reported cases, but this may merely mean that the effects are not regarded as unusual and not worthy of reporting. Four well documented cases have been described. All were on first exposure to d-tubocurarine. None were fatal although one patient had cardiac arrest (Harrison 1966) . All patients had allergic histories. Harrison (1966) described bronchospasm and hypotension in a patient with a history of asthma. West gate et al. (19tH) described massive urticaria and oedema, Salem et al. (1968) Both Brandus et al. (1970) and Bennett et al. (1970) have suggested d-tubocurarine caused bronchospasm but other causes were likely, and no sensitivity was demonstrated experimentally.
AlcuroniuJn
Alcuronium has been shown to release histamine in small quantities (Stovner and Lund 1970) . ~o cases of severe histamine mediated reactions have been described in detail although Heath (1 !)73) notes that cases have been reported to the British Committee of Safety on ;\Iedicines.
Gallamine
Lopert (1955) described the first cases showing anaphylactoid reactions confined to the skin. \Valmsley (1959) reported severe urticaria confirmed by skin testing. Watt (1 !)7~)) reported a case of hypotension and bronchospasm on second exposure to thiopentone, suxamethonium and gallamine.
Skin testing was highly suggestive of a sensitivity to gallamine (1 ·5 cm weal and 5 cm erythema at 1 : 10,000 dilution) but thiopentone and suxamethonium were not tested for. It is a pity more detailed study was not made as this would be the sole documented case of anaphylaxis to a muscle relaxant.
( -----
Pancuronillnl
Three cases have been described. Buckland and Avery (1973) described an asthmatic patient who showed bronchospasm, erythema and hypotension (transient) after first exposure. The time sequence suggested pancuronium to be the responsible drug and although skin testing was done, large volumes of undiluted solutions were used within the latent period of anaphylaxis and the tests were inconclusive. However, a subsequent anaesthetic substituting d-tubocurarine for pancuronium was uneventful.
Heath (1973) described bronchospasm as sole feature in an intubated asthmatic with negative results from skin testing. Clarke (1973) described bronchospasm occurring on three occasions during one anaesthetic in a non asthmatic and each incident followed pancuronium.
Skin testing was suggestive of sensitivity to pancuronium although concentrated solutions were used.
The cases are interesting as histamine release due to pancuronium in man or animals has not been demonstrated. This may mean that histamine release occurs only in-some patients or an alternative cause or unknown pharmacological action of the drugs responsible.
Suxametholl z"um
Three previously unreported cases are described. Skin testing in these three patients was carried out using initially 0·2 ml of 1 : 100 dilutions of the standard preparations used in our hospital, administered intradermally. In each case the author was tested at the same time as control and had no positive reactions. A weal of greater than 1 cm and flare of greater than f) cm persisting 30 minutes was regarded as a positi\'e result.
Case .3
A fit 28 year old woman who had had no previous an~esthesia and whose sole allergic history (elicited after the reaction) was wheezing after anti-diarrhoea tablets, was anaesthetized in the supine position for dental extractions. Premedication was pethidine f)O mg and atropine 0·6 mg. She \vas induced with methohexitone 70 mg and suxamethonium 50 mg, and intubated easily but was difficult to inflate and became cyanosed. The tube was changed with no improvement and the patient was found to be pulseless. Ascultation revealed no heartbeat and external cardiac compression was commenced and an intravenous infusion of saline commenced. Aminophylline (250 mg) was given intravenously and spontaneous respiration returned with audible rhonchi. Blood pressure rapidly rose to 50 mm/Hg and the patient awoke after five minutes. As the cyanosis vanished the skin became a vivid red colour which faded over the next two hours. Chlorpheniramine maleate 4 mg was given intravenously and a litre of saline administered. The blood pressure slowly returned to normal over five hours. The patient complained of no ill effect.
Two subsequent uneventful anaesthetics were given with steroid and antihistamine premedication and propanidid, nitrous oxide, oxygen, halothane sequence intubating with topical xylocaine 4 per cent. Four months later the patient was skin tested with 1 : 100 dilutions of thiopentone, methohexitone, suxamethonium, d-tubocurarine, and saline control, intradermally. The suxamethonium test was the sole positive reaction and the patient complained of tightness in the chest and palpitations ten minutes after injection. Pulse rate was 160/min. 0·5 ml of 1: 1000 adrenaline were injected subcutaneously and she felt normal after a further ten minutes.
Further testing was abandoned.
Case 4
A fit 29 year old woman with no allergic or asthmatic history was admitted for diagnostic laparoscopy. She had had two ethyl chloride/ ether anaesthetics as a child for squint repair. Premedication was pethidine 100 mg, promethazine 25 mg, and atropine 0·6 mg. Induction was with thiopentone 250 mg, gallamine 20 mg and suxamethonium 60 mg. The larynx was sprayed with 5 per cent cocaine and intubation was uneventful. Shortly after induction the patient became a bright crimson colour and blood pressure fell to 60 mg/Hg systolic with tachycardia of 150 beats/min. The operation was carried out.
Recovery of consciousness was prompt and the flush faded over 20 minutes.
A litre of saline was administered and the circulation returned to normal over two hours. The patient complained of intense cramping abdominal pain and nausea for four hours.
Skin testing was carried out two months later. Initially 1 : 100 dilutions of thiopentone, methohexitone, atropine, gallamine, d-tubocurarine, suxamethonium, cocaine and lignocaine were administered with saline as control, and positive reactions obtained to gallamine and suxamethonium. At 1 : 100,000 dilution the reaction to suxamethonium was still strongly positive and there was some reaction to gallamine though probably not significant. She was however, warned about both drugs.
Case 5
A 15 year old girl who gave no history of allergy or asthma was anaesthetized for extraction of teeth. (It subsequently turned out that the girl was a moderately severe asthmatic with a number of allergies, whose general practitioner told her she had bronchitis as a diagnosis of asthma upsets patients!) No premedication was given and she was induced with methohexitone 90 mg, gallamine 15 mg, and atropine o . 6 mg in the same syringe. This was followed by suxamethonium 75 mg. Inflation was easy and the larynx was sprayed with 4 per cent lignocaine, nasal intubation performed, and the pharynx packed. The patient could not be inflated. The pack and tube were removed and laryngoscopy was performed showing the cords still paralysed. She was now cyanosed and her radial pulse not palpable. The chair was tipped 25 degrees head down and she was ventilated with 100 per cent oxygen with the facemask but remained cyanosed with a weak pulse. H ydrocortisone (100 mg) was given intravenously and aminophylline (250 mg) intravenously over 20 minutes.
As her peripheral circulation improved, methoxamine 2·5 mg was given intravenously in divided doses.
After 90 minutes of oxygen administration she had normal skin colour, was awake, and only had rhonchi on deep inspiration. Blood pressure returned to normal over four hours and the patient complained of abdominal cramps and nausea, and vomited considerably over the next two days. She was not admitted to hospital. Skin testing was carried out 12 months later. She was initially tested with 1 : 100 dilution of atropine, gallamine, suxamethonium, dtubocurarine, thiopentone, methohexitone, lignocaine and saline control, and had a strongly positive reaction to suxamethonium only. An equally strong reaction occurred to 1: 10,000 dilution of suxamethonium. Her non asthmatic brother was also tested and all tests were negative.
Histamine mediated reactions to suxamethonium were first described by Smith (1951) ; three reactions were cutaneous and the fourth was bronchospasm in an asthmatic. Slavin and Howland (1959) used hexafluronium and suxamethonium for relaxation in six patients and found bronchospasm in all cases, with one fatality, but insufficient detail is given to determine the vast difference in their results from those of others who found the combination safe. Kepes and Haimovici (1959) , Sellini et al. (1963 ), Ferims et al. (1967 , BeleBinda and Valeri (1971) and Katz and Mulligan (1972) all described cases of bronchospasm as sole manifestation of histamine mediated reactions due to suxamethonium on first exposure !l92 !\J. McD. FISHER .and Eustace (1967) has described two such cases., F0~r of the patients had allergic or asthmat~c histories and all survived.
Decahicihonium has been shown to release histamirie i but no severe reactions have been described. '
OTHER DRUGS
P~nicillin.
Two severe anaphylactic reactions hirve been described by Cullen (1971) and Katz. e~ al. (1970) ; neither were fatal. 'Morphine has been described by Herxheimer (1950) to 'cause bronchospasm in asthmatics due to histamine release but no cases during anaesthesia have been reported. , [)extran is known to cause anaphylactoid r,eactions during anaesthesia and the effects have been discussed by Hewer and Lee (1957) .
H aemaceel has caused an anaphylactoid reaction during anaesthesia (Lund 1973 ) and a similar case has been reported to the New Zealand Committee on Adverse Drug Reactions (McQueen 1974) .
Trimetaphan is a known histamine releaser but no detailed cases of anaphylactoid reaction have been described.
Other histamine releasing drugs, while commonly producing such effects as transient rashes and erythema along veins, have not been described as causing severe histamine mediated reactions.
DRUG NOT DETECTED A number of cases have been described where the drug responsible has not been established as testing has not been done to exclude possibilities or a fatal result has meant testing could not be carried out.
Case 6
A 19 year old female with mild asthma occasionally requiring tablets, was admitted for caesarian section. The previous year she had had two uneventful general anaesthetics for fractured legs. These consisted of thiopentone, suxamethonium, pancuronium, nitrous oxide, oxygen, halothane, neostigmine and atropine, and thiopentone, nitrous oxide, oxygen and halothane. She had no known allergies. Premedication was 0·6 mg atropine and 15 ml mist. mag. trisilicate orally. She was preoxygenated and induced with thiopentone ~50 mg followed by suxamethonium 75 mg and d-tubocurarine chloride 30 mg in the same syringe. Cricoid pressure was applied and as intubation was performed with ease, the skin became blotchy.
After intubation it was impossible to inflate the patient and checking of the circuit and the tube revealed no abnormality. The radial pulse was not palpable and the carotid pulse was weak. Cyanosis rapidly occurred. A rapid drip was started and aminophylline 250 mg given intravenously in 1,000 ml saline over ten minutes, followed b,' 500 ml of 5 per cent dextrose. There was ne) improvement. Adrenaline 1 mg 1: 1,000 was given over 15 minutes intravenously and 450 ml 5 per cent sodium bicarbonate. There was no improvement. A further ~50 mg of intravenous aminophylline eased the ventilation somewhat and was followed by 8 mg dexamethasone. The pulse was still feeble and external cardiac compression was commenced.
Isoprenaline infusion was begun with little effect and ventricular fibrillation began 30 minutes after induction, with ventilation still difficult. Resuscitation and defibrillation were unsuccessful and the patient was pronounced dead an hour after induction. The post mort em finding was mild oedema of the lungs. The detection of the incriminating agent is of less relevance in this unfortunate case than when a subsequent anaesthetic is to be given. The causative agent could be thiopentone, suxamethonium or d-tubocurarine, or the case could be due to intubation per se. The three anaesthetists involved each believe a different drug responsible but admit no logic to their choice. There is also a possibility of supine hypotension syndrome playing a part.
Other 
Prevention
The major difficulty lies in detection of the patient at risk. Although Currie (1970) suggests that a past history of drug allergy is common and Hurwitz (1969) showed that a significant number of patients having a drug reaction have a history of previous reactions, such a history may not help. Cluff and Caldwell (1974) found an incidence of past history of drug reactions in 40 per cent of non hospitalized patients and the majority of the patients in Hurwitz (1969) study who had hypersensitivity reactions had previously reacted to structurally similar drug. The relative rarity of such reactions and the relative safety of the drugs involved meant that there are more important criteria in selecting the appropriate drug for a particular patient than its ability to release histamine, although there is probably a case for using the drug least likely to provoke such a reaction in an asthmatic or allergic patient when two drugs have similar action, e.g. alcuronium and dtubocurarine. It would also be practical to avoid using solely thiopentone for multiple anaesthetics or in patients with a long history of barbiturate taking or allergy to oral barbiturates.
In a patient with a history of reaction to althesin, propanidid may not be the safest alternative and vice versa. It is also sound practice to obtain optimum lung function in asthmatics before undertaking surgery. In a number of patients an allergic history or history of drug reaction is only obtained after a reaction and careful history taking is essential. A family history of allergic reactions in the absence of such a history in the patient may be a significant finding. If it is felt that a patient is at risk, preoperative sensitivity testing may be administered or test doses of drugs to be used could be administered cautiously. However, even test doses may produce a severe reaction.
The greatest positive contribution that can be made in prevention is to prevent further reactions in patients who have already had such a reaction by:
1. Adequate detection of the drug responsible; 2. Detailed explanation of the situation to the patient and provision of a detailed written account to be shown to subsequent anaesthetists; 3. The provision of a Medic Alert bracelet or medallion, naming the drug and reaction, to be worn by the patient; 4. A voiding the drug implicated, or all drugs used if possible. Careful preoperative history with detailed enquiry into allergic symptoms, asthma, family history of allergy, and drug reactions may enable more atopic individuals to be identified preoperatively.
In patients who have had such reactions, have asthma, or a history suggesting drug reactions, drugs which modify the response to histamine release may safely be incorporated in the premedication. ANTIHISTAMINES Douglas (1970) states that antihistamines will inhibit anaphylactoid but not anaphylactic reactions. Lorenz et al. (1972) showed that antihistamines will prevent effects due to mild histamine release but not massive histamine release, but demonstrated that the combination of glucocorticoids and powerful antihistamines could prevent a severe histamine mediated reaction in a patient who had previous anaphylactic reaction to propanidid. A number of cases have had anaphylactoid reactions in spite of promethazine 25 mg with the premedication. Assem (1971) 
DrSCCSSION
The use of antihistamines once reactions han' begun is not of proven benefit, as they depend for their action on competitive inhibition. However, as reactions may be delayed or prolonged, they should prob,ibly he usecl in all cases (Paterson and Kelly HI7cl) . Similarly the role of corticosteroids is controversial. Lorenz et al. (197~) believe they are essential treatmcnt and Paterson and Ke11y (197:!) state that while their rccommended use has little justificatioll and there is no evidence that they can act sufficiently rapidly to reverse anaphylaxis, they should be given for their potential benefit in hronchospasm, or prolonged hypotension. believe that adrenaline 1 : 1,000 0·3 ml intramuscularly is the most important treatment in anaphylaxis. I t must be remembered that (luring anaesthesia this drug ma\' he hazardous especially in the presence of cycloprolane, halothane, hvpercarhia or hypoxia.
The hypotension is due to fluid leakage and vasodilation, and fluid therapy should be aimed at correcting these defects. Plasma volume expanders are the logical choice of fluid initiall~' as they sta\' in the vascular compartmcnt. Saline or lactated I~ingers solution are used to replace fluid lost into the interstitial fluid; this loss may be considerable. Vasoconstrictors which ac"t peripherally are the logical choice as the abnormality is peripheral. They should be used cautiously as they can provoke acutt' pulmonary oedema in these circumstances.
The cases described in the literature confirm our own experience; that while a safe level of blood pressure can be achieved rapidly, efforts to restore normal blood pressure are usually fruitless. Once a safe pressure is reached, slow infusion of electrolyte solutions is preferred to rapid infusion. In treating the hypotension the peripheral circulation and colour are valuable signs.
Bronchospasm should also be treated vigorously as it is prominent in most fatal cases. Oxygen, ventilation, and bronchodilator drugs are employed as in treating severe asthma. Isoprenaline's effect on the peripheral circulation make it less suitable than adrenaline if hypotension is present. Aminophylline must be administered cautiously, particularly in the presence of hypoxia. In severe" total bronchospasm", local anaesthetics by spray or intravenously may help.
We have been unable to find any really satisfactory treatment for the distressing gastrointestinal symptoms. 
